Developer of sustainable cell-free enzyme technology pursuing uses that include active ingredients for nutraceuticals and pharmaceuticals, CEO Michael Heltzen tell GEN Edge
GEN Edge: What’s in a Name - Out with Invizyne, In with eXoZymes
0:12
Developer of sustainable cell-free enzyme technology pursuing uses that include active ingredients for nutraceuticals and pharmaceuticals, CEO Michael Heltzen tell GEN Edge
On June 11 this year, our CCO, Damien Perriman, was part of a panel discussing the use of AI in...